Imatinib dose escalation for chronic phase–chronic myelogenous leukaemia patients in primary suboptimal response to imatinib 400 mg daily standard therapy

Delphine Rea,Gabriel Etienne,Selim Corm,Pascale Cony-Makhoul,Martine Gardembas,Laurence Legros,Viviane Dubruille,Sandrine Hayette,Mahon Fx,J M Cayuela,Nicolini Fe

Imatinib dose escalation for chronic phase–chronic myelogenous leukaemia patients in primary suboptimal response to imatinib 400 mg daily standard therapy

2009

Delphine Rea
Gabriel Etienne
Selim Corm
Pascale Cony-Makhoul
Martine Gardembas
Laurence Legros
Viviane Dubruille
Sandrine Hayette
Mahon Fx
J M Cayuela
Nicolini Fe

Imatinib dose escalation for chronic phase–chronic myelogenous leukaemia patients in primary suboptimal response to imatinib 400 mg daily standard therapy

Keywords:

Cancer research
Oncology
Chronic myelogenous leukaemia
Intensive care medicine
Imatinib
Myelogenous leukaemia
Medicine
Internal medicine
dose escalation
standard therapy

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations